Community-designed HPV vaccination and home screening program for mothers and daughters in Nigeria

Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV)

NIH-funded research Washington University · NIH-11400258

This project uses community-made messages to help mothers and daughters in Nigeria get HPV vaccines for girls and HPV self-collection kits for women to screen for cervical cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University NIH-funded
Lab location1 site (Saint Louis, United States)
Project IDNIH-11400258 on NIH RePORTER

What this research studies

You and other community members will be invited to submit ideas and messages through local crowdsourcing contests so solutions come from people who know the culture. The team will adapt the best community-designed messages and share them through channels that mothers and daughters already use. Mothers (or female caregivers) and their daughters will be offered HPV vaccination for girls aged 9–26 and HPV self-collection screening support for women aged 30–49, with local clinics and outreach workers helping with delivery. The project focuses on making the approach easy to use and acceptable in everyday family settings.

Who could benefit from this research

Good fit: Ideal participants are mother–daughter pairs in Nigerian communities, with daughters aged 9–26 for vaccination and mothers or female caregivers aged 30–49 for HPV self-collection screening.

Not a fit: People who live outside the participating Nigerian communities or who are outside the target age groups for vaccination or screening are unlikely to get direct benefit from this program.

Why it matters

Potential benefit: If successful, this could increase HPV vaccination for girls and early detection of cervical changes in women, lowering cervical cancer rates in participating communities.

How similar studies have performed: Community engagement and crowdsourced messaging have helped improve uptake of other health services in similar settings, though applying this exact mother–daughter HPV approach in Nigeria is relatively new.

Where this research is happening

Saint Louis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusCancer BurdenCancer ControlCancer Control Science
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.